Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.
about
Clindamycin as an antimalarial drug: review of clinical trials.Multiple dose study of interactions between artesunate and artemisinin in healthy volunteersArtemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialPregnane X receptor and natural products: beyond drug-drug interactionsCombinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics.Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.Artemisinin drugs: novel antimalarial agents.Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimensArtemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.Antimalarial drug resistance and combination chemotherapy.Artemisinins.A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria.A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction.Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.Access to artemisinin combination therapy for malaria in remote areas of Cambodia.Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children.Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases.Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers.Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.Malaria treatment using novel nano-based drug delivery systems.Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisininFirst assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisoneCharacterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling.Therapeutic equivalence of a low dose artemisinin formulation in falciparum malaria patients.Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.More insights into the pharmacological effects of artemisinin.Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria.Artemisinin-Based Combination Therapy Depressed Mitosis and Induced Chromosome Aberration in Onion Root Cells
P2860
Q24536057-A54C8BA1-C735-4098-9ACF-ACBB7D4CD0EAQ28362543-E3FF43F9-4E52-4FFB-9557-A14FC0BD127EQ28542921-B7A09349-35B0-4231-AE3B-A965F5BD3486Q28748504-BBD177EB-CB1D-4779-850B-6CA6092C8E21Q33979461-ADF049E7-DFC7-430C-90E3-CF6BA0B96E3BQ33982362-629AA1A8-D114-43DB-B6B0-E223B3992875Q34075018-59470072-95C2-4F57-BE0A-9B3B9960FC67Q34105652-7728180E-6F81-48D6-9371-E4504DD9FE8CQ34172447-BAC47437-7093-4123-AC18-0CDC089C95DBQ34734703-7FF2CA4A-7DD7-4E7B-BFBF-52E3208866E5Q35212414-6B6C7DD1-0373-4648-9793-F884A639257CQ35521094-D89D9766-ADE5-45D5-A565-ED036998814EQ35802096-B785D9FD-2428-42FB-B71F-8A117F48D778Q35803021-8E3CA608-FE4D-43A2-8411-9BD429F13233Q35826682-3E469BDE-192E-40A9-8192-484C0575144DQ35827084-3BB1C110-D58A-4095-A202-53365088B86AQ35860086-0D53738C-DAEA-4254-A24D-482C837E9D7FQ35941440-90369221-4B02-4FB5-B852-A8CE629DEB36Q35941455-279B4ED9-F516-4979-8B00-6A3786048A2EQ36018642-29C013EE-72AA-4A37-92D6-9494E314AFE4Q36138872-A7989A34-7D68-4E7F-B77E-27624F6C5F5BQ36364184-ACE91C7F-0300-426C-A715-576B8D740936Q36669256-DB416B6B-5D94-4EE9-B8A2-11EED832F972Q36726339-56D3019D-38C7-422C-846F-E499E5C9BCA2Q37517983-4E4D4EF5-0582-44DA-9677-21E008356556Q37885184-7EEF3153-C34D-4C90-A5F2-0BBB51CCBC5BQ38487882-8A6E286F-115A-4F65-AA67-9B16D3E19F1AQ38973078-165E5386-00A1-49D0-B66A-B633FD118121Q39122575-3A4D618D-0F67-4F9B-B499-A0DFB13082AEQ39132767-74F05CC8-9042-4E18-9B81-E5185CCEBB6AQ40914424-DD3ED1F9-D39E-4F4F-BB97-AFE053D24887Q42445249-6F3B234A-1C54-4432-98A8-3586F080A203Q44347372-863A9DD4-4915-4E4F-9E5A-D7F61D06C26CQ44358811-BCC9A76D-C0AF-4EBA-A2B1-3EF92C768B95Q44872854-4DEC4EAC-C612-49E9-A1F1-1E74EA5ABACEQ46250415-FD73E8CF-2D42-4046-AD00-1667CDAFF369Q47833388-FF6156C7-CEEA-48F0-896F-1298886B41FEQ47967717-6BFC764A-4765-4885-A8C4-ECB370C01ACCQ58711572-24FC88D3-E99A-495A-88B1-9E8910379D71
P2860
Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Multiple dose pharmacokinetics ...... n falciparum malaria patients.
@en
type
label
Multiple dose pharmacokinetics ...... n falciparum malaria patients.
@en
prefLabel
Multiple dose pharmacokinetics ...... n falciparum malaria patients.
@en
P2093
P2860
P921
P1476
Multiple dose pharmacokinetics ...... n falciparum malaria patients.
@en
P2093
P2860
P356
10.1016/S0035-9203(96)90480-0
P577
1996-01-01T00:00:00Z